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A B S T R A C T
Background: The relationship between aortic stiffness and coronary artery disease has been proven.
Logistic Clinical SYNTAX score (LogCSS), which combined the anatomical evaluation of coronary artery
disease and three clinical factors (age, left ventricular ejection fraction, and creatinine clearance),
showed improved predictive value for cardiovascular events in patients after percutaneous coronary
intervention (PCI). The combination of pulse wave velocity (PWV) and clinical factors may show
equivalent predictive value.
Methods: Three hundred and seventy-six patients who were diagnosed with non-ST-segment elevation
coronary syndrome (ACS) and showed at least one 50% angiographic stenosis in a major coronary artery
were enrolled. The Clinical PWV score was calculated by assigning points to different levels of age,
creatinine clearance, left ventricular ejection fraction, and carotid–femoral PWV (cfPWV). The points for
cfPWV were determined based on the cutoff values of quintiles (model 1) or the relationship between
cfPWV and SYNTAX scores (model 2). The predictive values of LogCSS and Clinical PWV score for 3-year
major adverse cardiac events (MACE), which were deﬁned as all-cause death, nonfatal myocardial
infarction, and nonfatal target vessel revascularization, were analyzed in 298 patients undergoing PCI.
Results: The Clinical PWV score based on model 2 demonstrated a similar predictive ability for 3-year
MACE compared with LogCSS (AUC 0.72 vs. 0.75; p = 0.11). The AUC of LogCSS was signiﬁcantly higher
than the AUC of Clinical PWV score based on model 1 (AUC = 0.70, p = 0.03). Compared with cfPWV in
isolation (AUC = 0.61), Clinical PWV score from model 2 showed signiﬁcantly better predictive power
(p = 0.03).
Conclusion: Combination of PWV with age, creatinine clearance, and left ventricular ejection fraction
appears to be a promising tool to predict MACE after PCI in patients with ACS.
 2014 Japanese College of Cardiology. Published by Elsevier Ltd. All rights reserved.
Contents lists available at ScienceDirect
Journal of Cardiology
jo u rn al h om ep age: ww w.els evier .c o m/lo c ate / j j c cIntroduction
The relationship between aortic stiffness and coronary artery
disease (CAD) has been proven in previous studies [1–3]. Several
pathophysiological phenomena during the development of coro-
nary atherosclerosis, including accumulation of collagen, ﬁbrosis,
inﬂammation, medial smooth muscle necrosis, and calciﬁcations,
are known to occur in parallel at the site of aorta accompanying age* Corresponding author at: Department of Cardiology, Fuwai Hospital, 167 Beilishilu,
Beijing 100037, People’s Republic of China. Tel.: +86 10 88398040;
fax: +86 10 88396323.
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0914-5087/ 2014 Japanese College of Cardiology. Published by Elsevier Ltd. All rightsand cardiovascular risk factors, which may induce aortic stiffening
[4,5]. As the gold-standard measurement of aortic stiffness,
carotid–femoral pulse wave velocity (cfPWV) shows independent
predictive value for cardiovascular events [6,7].
SYNTAX score is an anatomically based tool to quantitatively
assess and grade the angiographic characteristics of coronary
lesions [8], which has been shown as a predictor of long-term
prognoses in patients after coronary revascularization [9,10].
However, one important limitation of SYNTAX score is the lacking
of clinical variables in its algorithm. Recently, several SYNTAX
score-derived risk scores which combine clinical-based scores
with SYNTAX score have been proposed [11], such as Clinical
SYNTAX score (CSS) that multiplies the modiﬁed ACEF [Age,
Creatinine clearance (CrCl) and left ventricular Ejection Fraction reserved.
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score (LogCSS) that grades the SYNTAX score and the 3 clinical
variables in ACEF score and then assigns different points [13]. In
consideration with the relationship between CAD and aortic
stiffness, we hypothesized that the combination of PWV and the
ACEF score may show equivalent predicting value with LogCSS.
In this study, we ﬁrst assessed the relationship between cfPWV
and SYNTAX score, and attempted to develop models to combine
the results of cfPWV and 3 clinical factors (age, creatinine
clearance, and ejection fraction). The predictive value of these
models was assessed and compared in a cohort prospectively.
Methods
Study population
We enrolled 376 consecutive patients who were diagnosed as
having non-ST-segment elevation acute coronary syndrome (ACS)
and showed at least one signiﬁcant angiographic coronary lesion at
the Fuwai Hospital in 2010. A coronary lesion with 50% reduction
of the luminal diameter in vessel 1.5 mm was deﬁned as a
signiﬁcant lesion [8]. Non-ST-segment elevation ACS was deﬁned
according to the American College of Cardiology Foundation/
American Heart Association guideline for the management of
patients with unstable angina/non-ST-elevation myocardial in-
farction [14]. Exclusion criteria included a history of percutaneous
coronary intervention (PCI) or coronary arterial bypass grafting
(CABG), and a diagnosis of acute ST-segment elevation myocardial
infarction, valvular heart disease, or congenital heart disease. The
study was approved by the Ethics Committee of the Fuwai
Hospital.
Logistic Clinical SYNTAX score (LogCSS)
The results of angiography were reviewed by two experienced
interventional cardiologists, and the SYNTAX scores were assessed.
Each coronary lesion with 50% reduction of the luminal diameter
in vessel 1.5 mm was scored separately. The SYNTAX algorithm
which is available on the SYNTAX website (www.syntaxscore.com)
was used to calculate the overall score. The Logistic Clinical
SYNTAX score system has been detailed previously, and the core
model was used in this study [13]. In brief, points were assigned
according to the values of four variables including age, LVEF, CrCl,
and SYNTAX score, and the sum of these points was the result of
LogCSS. The CrCl was calculated using the Cockcroft and Gault
formula [15]. LVEF was calculated by echocardiographic assess-
ment using Simpson’s method.
Clinical cfPWV and Clinical PWV score
Carotid–femoral PWV was measured using the SphygmoCor
system (AtCor Medical, Sydney, Australia). Electrocardiogram-
gated carotid and femoral waveforms were recorded by applana-
tion tonometry. The distance between the sampling sites (carotid
and femoral sites, Dcf) was measured manually above the body
surface with a tape. PWV was calculated by dividing this distance
by the carotid–femoral transit time which was estimated as the
average time difference between the onset of the femoral and
carotid waveforms of 10 consecutive cardiac cycles.
We used the formula age/LVEF + 1 point for every 10 mL/min
reduction in CrCl below 60 mL/min per 1.73 m2 (up to a maximum
of 6 points) to calculate the modiﬁed ACEF score, which has been
detailed previously [10]. The Clinical cfPWV was calculated using
the formula cfPWV  modiﬁed ACEF score.
We used 2 models to assign points to different values of cfPWV.
In model 1, the results of cfPWV were divided into quintiles, andpoints of 0–4 were assigned to each quintile. The lowest quintile
got 0 point, and the highest quintile got 4 points. To develop model
2, we ﬁrst investigated the mean SYNTAX scores in categories with
different cfPWV levels. Based on the characteristics of distribution
of SYNTAX score, we ﬁxed the cutoff values of cfPWV for different
points. We used these points to replace the points from SYNTAX
score in the LogCSS model and constructed the model of Clinical
PWV score. We gave 1 point for every 5 years increase up to a
maximum of 7 points in age above 50 years old to calculate the
scores for age, 2 points for every 5 mL/min per 1.73 m2 reduction
up to a maximum of 10 points in CrCl below 90 mL/min per
1.73 m2, and 2 points for every 5% reduction in LVEF below 50% up
to a maximum of 10 points. The sum of these scores plus the scores
of PWV was the result of Clinical PWV score.
Follow-up of patients after PCI
The patients who underwent PCI were monitored every 6 months
via formal telephone interviews or during their visits to the clinic.
Major adverse cardiac events (MACE) were recorded which were
deﬁned as all-cause death, nonfatal myocardial infarction (MI), and
nonfatal target vessel revascularization (TVR) [16]. MI was deﬁned
as chest pain with new ST-segment changes and elevation of cardiac
markers which reﬂected myocardial necrosis to at least twice the
upper limit of normal. PCI-related MI was not included as clinical
events in this study. TVR was deﬁned as clinically driven
percutaneous revascularization or bypass of the target lesion or
any segment of the epicardial coronary artery that contained the
target lesion.
Statistic analysis
Spearman’s correlation test was used to assess the association
between continuous variables. The discriminating power to predict
MACE was assessed by the area under the receiver operating
charactering curve (AUC), which is equal to the c-statistic [17].
The c-statistic estimates the ability to distinguish a patient with and
without a clinical outcome, and ranges from 0.5 (no discrimination)
to 1 (theoretical maximum). AUCs were compared using the
method described by DeLong [18]. All the data analyses were
conducted using SPSS software version 19.0 (SPSS Inc., Chicago, IL,
USA). Statistical signiﬁcance was set at a two-side p < 0.05.
Results
Characteristics of patients
The mean age of these 376 patients was 56.4  10.2 years, 320
(85.1%) of them were male. PCI was performed in 316 patients, and
CABG was performed in 34 patients. The details of the clinical
characteristics are presented in Table 1.
Clinical cfPWV
A signiﬁcant correlation between cfPWV and SS was observed
(r = 0.27, p < 0.001; Fig. 1). A signiﬁcant correlation was presented
between Clinical cfPWV and LogCSS (r = 0.78, p < 0.001).
Models of Clinical PWV score
In the model 1 of Clinical PWV score, we categorized the results
of cfPWV into quintiles with cutoff values as 7.2, 7.3–7.9, 8.0–9.0,
9.1–10.1, 10.2. Each quintile was assigned the points of 0–4. The
mean SYNTAX scores in different categories with different cfPWV
are presented in Fig. 2. The cutoff values for points of 0–4 in model
2 were ﬁxed as 8.0, 8.1–9.0, 9.1–10.0, 10.1–12, 12.1. The
Fig. 1. Relationship between SYNTAX score and cfPWV. cfPWV, carotid–femoral
pulse wave velocity.
Fig. 2. The mean SYNTAX scores in different categories with different value of
cfPWV. cfPWV, carotid–femoral pulse wave velocity.
Fig. 3. The relationship between LogCSS and Clinical PWV score. The score charts of mod
CrCl, creatinine clearance; LogCSS, Logistic Clinical SYNTAX score; LVEF, left ventricula
Table 1
Basic characteristics of patients.
Patients
n = 376
Age (years) 56.4  10.2
Male, n (%) 320 (85.1)
BMI (kg/m2) 26.2  3.0
Current smoking, n (%) 264 (70.2)
Family history, n (%) 16 (4.3)
Hypertension, n (%) 254 (67.6)
Hyperlipidemia, n (%) 258 (68.6)
Diabetes, n (%) 124 (33.0)
Total cholesterol (mmol/L) 4.4  1.2
CrCl (mL/min per 1.73 m2) 95.5  23.8
LVEF (%) 65.1  6.0
SYNTAX score 20.4  13.2
LogCSS 4.8  4.1
cfPWV, (m/s) 8.9  2.2
PCI, n (%) 316 (84.0%)
CABG, n (%) 34 (9.0%)
BMI, body mass index; CABG, coronary artery bypass
grafting; cfPWV, carotid–femoral pulse wave velocity; CrCl,
creatinine clearance; LogCSS, Logistic Clinical SYNTAX score;
PCI, percutaneous coronary intervention.
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by models 1 and 2 and the score charts are presented in Fig. 3.
Predicting MACE after PCI
PCI was performed in 316 patients, and 3-year follow-up was
completed in 298 (92.4%) of these patients. Four patients died, and
nonfatal MI occurred in 5 patients. Nonfatal TVR was observed in
11 patients. MACE with different Clinical PWV scores are
presented in Table 2. The ROC curves of LogCSS, Clinical cfPWV,
and Clinical PWV score to predict MACE are presented in Fig. 4. The
Clinical PWV score based on model 2 demonstrated a similar
predictive ability for 3-year MACE compared with LogCSS (AUC
0.72 vs. 0.75; p = 0.11). The AUC of LogCSS was signiﬁcantly higher
than the AUC of Clinical PWV score based on model 1 (AUC = 0.70,
p = 0.03). Compared with Clinical cfPWV (AUC = 0.65) and cfPWV
in isolation (AUC = 0.61), Clinical PWV score based on model 2
showed signiﬁcantly better predictive power (p = 0.02 and 0.03,
respectively).el 1 and model 2 are also illustrated. cfPWV, carotid–femoral pulse wave velocity;
r ejection fraction.
Table 2
MACE with different Clinical PWV scores.
Clinical PWV score (model 2) 0–1 2–3 4–5 6–10 11
Number of patients 62 76 42 64 54
Number of MACE 2 2 2 6 8
PWV, pulse wave velocity; MACE, major adverse cardiac events.
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In this study, a signiﬁcant correlation between cfPWV and
SYNTAX score was conﬁrmed in the cross-sectional study. The new
risk stratiﬁcation models by replacing SYNTAX score with cfPWV in
the CSS and LogCSS showed good consistency with LogCSS.
Compared with cfPWV alone, Clinical PWV score which combined
cfPWV and 3 other clinical factors (age, LVEF, and CrCl) showedFig. 4. Receive-operating characteristic (ROC) curves for cfPWV, Logistic SYNTAX score 
cardiac events (MACE). cfPWV, carotid–femoral pulse wave velocity.higher predictive value for 3-year MACE in patients after PCI in the
prospective study.
The ACEF score, which used only 3 clinical variables (age, LVEF,
and CrCl), has been proven to have comparable accuracy with
EUROscore to predict mortality in patients after CABG [19]. The
ACEF score does not include traditional risk factors, such as
smoking, cardiovascular disease family history, hypertension,
diabetes, hyperlipidemia, and obesity. In our opinion, LVEF and
CrCl actually reﬂect the integrated damage caused by these risk
factors in cardiac and urinary systems. In addition, ACEF score may
also reﬂect some potential factors outside our knowledge at
present, which may be explained as individual susceptibility to
known factors. In terms of the strategy that uses the manifestation
of end organs to stratify the risk of mortality, it is reasonable to add
the evaluation of damage in other end organs into the scoring
system to improve the predictive accuracy. The proposer of
ACEF score also recommended adding other variables to get an(LogCSS), Clinical cfPWV, and Clinical PWV score, predicting 3-year major adverse
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cardiovascular disease, the addition of anatomical and functional
evaluation of the artery system appears to be a good choice.
Garg et al. [12] found CSS, which is determined by multiplying
SYNTAX score and modiﬁed ACEF score value, had a better
discriminating power for 1-year mortality and MACE than either
SYNTAX score alone or ACEF. However, CSS had a relatively poor
discriminating power, especially in its lower 2 tertiles. In our study,
the Clinical cfPWV, which is determined by multiplying cfPWV and
modiﬁed ACEF score, showed no additional predictive power
compared with cfPWV alone. Simply multiplying ACEF score and
other clinical variables does not appear to be the optimal strategy.
The variables of LogCSS were selected based on the logistic
regression coefﬁcients. Compared with SYNTAX score, LogCSS
showed a substantial improvement to predict mortality in patients
with ACS after PCI [21]. In the present study, Clinical PWV score
was determined using the similar score charts as LogCSS and
showed an additional power to predict 3-year MACE in patients
with ACS after PCI compared with cfPWV. The model with higher
cutoff values (model 2) had better discriminating power than the
model with lower cutoff values (model 1). In the European Society
of Hypertension/European Society of Cardiology guidelines for the
management of arterial hypertension, a threshold of >10 m/s was
suggested as the marker of signiﬁcant alterations of aortic function
[22]. In model 2, values of cfPWV higher than 10 m/s were
categorized into 2 groups with different scores, while they all got a
same score in model 1. Thus, Clinical PWV score based on model 2
had better discriminating power for risk estimation in patients
with abnormal aortic stiffness, which may explain its advantage
over the score based on model 1.
It has been shown that PWV was an independent predictor of
cardiovascular outcomes in various populations. Vlachopoulos
et al. [7] proved that PWV was a strong predictor of cardiovascular
events more than conventional risk factors in high cardiovascular
risk population. Maldonado et al. [23] found that PWV could be
used to predict cardiovascular outcomes in a low-to-moderate
cardiovascular risk population. Pereira et al. [24] reported that the
combination of PWV with HeartSCORE showed a better discrimi-
native capacity of major cardiovascular events than HeartSCORE
alone. To the best of our knowledge, our data ﬁrst proved the
predictive value of PWV in a high-risk CAD population undergoing
PCI.
The correlation between aortic stiffness and CAD has been
proven in previous studies [1–3]. The aortic stiffness is a result of
integration with various phenomena, including inﬂammation,
calciﬁcation, accumulation of collagen, and ﬁbrosis, which occur at
the coronary artery in parallel [4,5]. As a result, measurement of
aortic stiffness and CAD both reﬂect the integrated results caused
by various cardiovascular risk factors. Carotid–femoral PWV is
considered as the ‘‘gold-standard’’ measurement of aortic stiffness
[5]. In previous studies, cfPWV showed additive predicting value
beyond traditional risk factors [6,7]. Although the predictive value
of SYNTAX score has been proven in several studies, it has several
limitations, including interobserver variability, poor calibration,
and not distinguishing ischemic-producing lesions [25]. Neverthe-
less, angiography is usually considered in selective patients with
CAD related syndromes, which means SYNTAX score and other
SYNTAX score-derived scores can only be used in limited patients.
However, PWV can be measured with non-invasive methods easily
and safely in any patient. Clinical PWV score can be used to predict
the risk of patients without coronary angiography.
In this study, we assigned the points to different PWV values
based on their relationship with SYNTAX score, other than the
relationship with clinical outcomes which was used in the
development of LogCSS by regression analysis. The validation of
Clinical PWV score was tested in a small size cohort. We preferredto take our study as a primary attempt to call for more research to
verify and modify the scoring system based on PWV.
Conclusion
The Clinical PWV score presented similar predictive value with
the LogCSS. The scoring system that combines PWV with age, LVEF,
and CrCl appears to be a promising tool to predict MACE after PCI.
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